WinstonWınston
Back
Stock

SurgLine International

SGLN
Electrical Equipment & Parts · Industrials
Price
$0.00
+0.00 (+0.00%)
Market Cap
$569,012
Exchange
Other OTC
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+2563.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 200.8M (2008) → 5.35B (2012)

§Winston Score History

The full picture

SurgLine International is a small company that sells surgical instruments and medical devices to hospitals, clinics, and healthcare distributors. Its products include items like forceps, scissors, retractors, and other tools that surgeons use during operations. The company sources and distributes these instruments, primarily serving customers in the United States.

SurgLine makes money by selling medical instruments, typically purchasing them from manufacturers and reselling them to healthcare providers. It is a micro-cap company with very limited revenue, and its deeply negative operating margin shows it spends far more than it earns as it tries to build its business. The company operates in a competitive market dominated by much larger surgical instrument makers with established relationships and scale advantages. The key risk for SurgLine is whether it can grow revenue fast enough to cover its operating costs and become profitable, as companies this small face significant challenges with funding and market access.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+52.4% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (4%)

Research and development spending

Insider Activity

23.1%ownership

Insiders own a meaningful stake in the company

Cash Runway

~1 months

$7,467 cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

SurgLine International has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
231.2%
Premium pricing power — 231.2% gross margin
Profit after running costs
Operating Margin
2541.4%
Excellent — 2541.4% operating margin
Return on the money invested
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-315.9%
Burning cash (-315.9%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial